Results 151 to 160 of about 63,717 (177)

Systemic mastocytosis and osteoporosis

Osteoporosis International, 1993
A, Chines, R, Pacifici, L A, Avioli, P E, Korenblat, S L, Teitelbaum   +4 more
openaire   +2 more sources

Tyrosine kinase inhibitors for the treatment of indolent systemic mastocytosis: Are we there yet?

Journal of Allergy and Clinical Immunology, 2022
Cem Akin, Michel Arock, Peter Valent
exaly  

Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification

Allergy: European Journal of Allergy and Clinical Immunology, 2020
Jakub Trizuljak, Wolfgang R Sperr, Lucie Nekvindová   +2 more
exaly  

Systemic Mastocytosis

Hematology/Oncology Clinics of North America, 2012
Dean D Metcalfe, Sarah Austin, Peter Valent   +2 more
openaire   +2 more sources

Systemic Mastocytosis

2007
openaire   +2 more sources

Importance of Adequate Diagnostic Workup for Correct Diagnosis of Advanced Systemic Mastocytosis

Journal of Allergy and Clinical Immunology: in Practice, 2020
Juliana Schwaab, Nicole Naumann, Mohamad Jawhar   +2 more
exaly  

Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis

Journal of Allergy and Clinical Immunology, 2016
Ivan Alvarez-Twose, Maria Jara-Acevedo, JOSÉ Mario Morgado   +2 more
exaly  

Mast cells from different molecular and prognostic subtypes of systemic mastocytosis display distinct immunophenotypes

Journal of Allergy and Clinical Immunology, 2010
Cristina Teodosio, Andres C Garcia-Montero, Maria Jara-Acevedo   +2 more
exaly  

Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study

Lancet, The, 2017
Olivier Lortholary, C Bulai Livideanu, C Paul   +2 more
exaly  

Eosinophilia in systemic mastocytosis: Clinical and molecular correlates and prognostic significance

Journal of Allergy and Clinical Immunology, 2007
Alexandra Bohm, Manuela Födinger, Friedrich Wimazal   +2 more
exaly